Vitamin A in Nutrition, Immunity, and Disease

Vitamin A consistently ranks among the most searched micronutrients, and the questions behind those searches are practical rather than academic: what a "vitamin A blood test" actually measures, whether low intake is causing night blindness, how much is too much, whether beta-carotene is a safe substitute for retinol, and what the result means during pregnancy. Our catalog supports that work with validated immunoassays for serum retinol, retinol-binding protein 4 (RBP4), retinoic acid, and individual carotenoids, matched antibody pairs for retinoid-signaling targets, and custom assay development for laboratories building in-house panels. This article focuses on vitamin A itself — how the body uses it, where deficiency and excess strike, what it does in the immune system, and how to interpret the common tests without over-reading a single number.

What the Body Actually Uses

"Vitamin A" is a label for a family of fat-soluble retinoids and plant carotenoids that share one defining activity: supporting vision, epithelial integrity, immune competence, and cellular differentiation. The preformed retinoids — retinol, retinal, and retinoic acid — come from animal foods such as liver, eggs, and dairy and are the forms the body can use directly, while provitamin A carotenoids like beta-carotene are plant pigments the intestine converts into retinol. These forms are not interchangeable in every context: retinol is the transport and storage currency, retinal is the chromophore of the visual cycle, and retinoic acid is the locally produced ligand that switches on nuclear receptors and drives gene transcription. Roughly 80% of total-body vitamin A sits in the liver as retinyl esters, and in the fasting circulation more than 95% travels as retinol bound to its carrier retinol-binding protein 4 and the stabilizing protein transthyretin. That distribution is exactly why a single "vitamin A level" is ambiguous — it may mean serum retinol by chromatography, total RBP4 by immunoassay, a carotenoid profile, or a hepatic reserve estimate, and each answers a different question.

Figure 1. Vitamin A metabolic pathway. (Source: Guo X, et al. 2022)

Deficiency: Who Is at Risk and What It Looks Like

Deficiency remains a leading cause of preventable childhood blindness and a contributor to infection-related mortality, concentrated in young children and pregnant women in low-income settings; a 2021 global-burden analysis attributed over 45% of vitamin A–related disability to children under five. The clinical progression is well characterized. Early, still-reversible signs include growth faltering, reduced resistance to infection, and night blindness caused by depleted retinal in the visual cycle; severe, sustained deficiency produces xerophthalmia and irreversible corneal damage. Because circulating retinol is tightly homeostatically buffered, a normal serum retinol value can hide depleted liver stores, so population surveys rely on cutoffs such as serum retinol below 0.70 µmol/L and on functional or isotope-dilution tests when true reserve — rather than current supply — is the real question. The practical takeaway for anyone searching "vitamin A deficiency symptoms" is that subtle immune and growth effects precede the dramatic eye signs, which is why supplementation programs target asymptomatic risk groups instead of waiting for blindness to appear.

Too Much: Toxicity, Teratogenicity, and the Beta-Carotene Caution

At the other extreme, excess preformed vitamin A is genuinely toxic. Acute high doses cause headache, nausea, and blurred vision from raised intracranial pressure, whereas chronic overconsumption is linked to liver injury and a higher fracture risk. The sharpest warning is teratogenicity: high-dose retinol in early pregnancy can cause birth defects, which is why guidance carefully separates therapeutic use from routine intake. A meta-analysis of pregnancy supplementation reported benefits for preterm birth and low birth weight without excess harm at doses up to 4000 µg RAE per day, but the teratogenic threshold makes unsupervised high-dose use unsafe. Beta-carotene adds a separate lesson: although it is a safe provitamin A source for most people, two large trials in smokers and former smokers found that high-dose beta-carotene increased lung-cancer incidence, and because conversion to retinol is inefficient and suppressed by low fat intake, infection, and poor nutrition, it is a poor substitute for retinol when correction of true deficiency is the goal. Those same safety signals reshaped eye-health supplements, where lutein and zeaxanthin — carotenoids with no vitamin A activity — replaced beta-carotene after a large randomized trial showed they reduced progression to late macular degeneration without the excess lung-cancer signal.

Vitamin A and the Immune System

Vitamin A's immune role is mechanistic rather than folk belief. Retinol and retinoic acid maintain the integrity of mucosal epithelia — skin, gut, respiratory, and urogenital surfaces — and retinoic acid promotes secretory IgA at those barriers while steering T-cell differentiation toward regulatory and tolerant phenotypes and damping excessive pro-inflammatory signaling. These effects explain why deficiency worsens diarrheal and respiratory infection and why measles mortality drops with supplementation. More recently, reviews have examined whether adequate retinol supports mucosal IgA responses against respiratory viruses, including SARS-CoV-2, framing vitamin A as an affordable adjunct to — not a replacement for — vaccination and antiviral care. The key research implication is that immune outcomes track local retinoid signaling and barrier status, not a single serum retinol number, so studies increasingly pair retinol status with carotenoid and functional readouts instead of reporting one value in isolation.

Figure 2. Retinoic acid induces T cell homing to the gut. (Source: Bono MR, et al. 2016)

Measurement Notes

What to watch when you run or interpret a vitamin A panel

• Method matters. Serum retinol by HPLC is the reference method; immunoassays for RBP4 are cheaper but read total RBP4, not the retinol-carrying holo fraction.
• Retinol is buffered. A normal retinol value does not prove adequate liver stores — use retinol isotope dilution or relative-dose tests when reserve, not supply, is the question.
• Fasting for toxicity. Assess excess from fasting retinyl esters; values above 5–7.5% of total vitamin A indicate hypervitaminosis.
• Carotenoids need chromatography. Matrix effects and lipemia shift values; report a profile rather than a single number, and note fat intake.
• Retinoic acid is not routine. It is a local signaling metabolite — interpret activity via receptor or target-gene readouts, not a serum level.
• Cutoffs differ by purpose. WHO uses serum retinol <0.70 µmol/L to flag a population problem; RBP4 has no universal cutoff, so pair it with context (renal, hepatic, nutritional).
• Handle as fat-soluble. Protect from light, avoid hemolysis, keep samples cold, and standardize pre-analytical handling before comparing across studies.

Outlook

The field is shifting away from a single "vitamin A level" toward multi-analyte status assessment — retinol plus RBP4 (ideally the holo-RBP fraction that is actually carrying retinol), a carotenoid profile, and, where needed, retinol isotope dilution for true hepatic reserves — interpreted against dietary fat, infection, renal, and hepatic context. Better assay standardization and agreed RBP4 cutoffs would make cross-study comparison credible. For assay development, the opportunity lies in matched, fruit-and-vegetable–indexed carotenoid panels and in holo-RBP formats that finally separate empty carrier from true retinol transport, giving researchers a cleaner read on whether a sample reflects supply, reserve, or local signaling state.